Ardissino Gianluigi, Perrone Michela, Tel Francesca, Testa Sara, Morrone Amelia, Possenti Ilaria, Tagliaferri Francesco, Dilena Robertino, Menni Francesca
Center for HUS Prevention Control and Management, Fondazione IRCCS Ca' Granda Osp. Maggiore Policlinico, Milan, Italy.
Paediatric Neurology Unit and Laboratories, Neuroscience Department, Meyer Children's Hospital, Florence, Italy.
Case Rep Pediatr. 2017;2017:2794060. doi: 10.1155/2017/2794060. Epub 2017 Aug 1.
Hemolytic uremic syndrome (HUS) is an unrare and severe thrombotic microangiopathy (TMA) caused by several pathogenetic mechanisms among which Shiga toxin-producing infections and complement dysregulation are the most common. However, very rarely and particularly in neonates and infants, disorders of cobalamin metabolism (CblC) can present with or be complicated by TMA. Herein we describe a case of atypical HUS (aHUS) related to CblC disease which first presented in a previously healthy boy at age of 13.6 years. The clinical picture was initially dominated by nephrotic range proteinuria and severe hypertension followed by renal failure. The specific treatment with high dose of hydroxycobalamin rapidly obtained the remission of TMA and the complete recovery of renal function. We conclude that plasma homocysteine and methionine determinations together with urine organic acid analysis should be included in the diagnostic work-up of any patient with TMA and/or nephrotic syndrome regardless of age.
溶血性尿毒症综合征(HUS)是一种并不罕见的严重血栓性微血管病(TMA),由多种致病机制引起,其中产志贺毒素感染和补体失调最为常见。然而,非常罕见的是,特别是在新生儿和婴儿中,钴胺素代谢紊乱(CblC)可表现为TMA或并发TMA。在此,我们描述一例与CblC疾病相关的非典型HUS(aHUS)病例,该病例首次出现在一名13.6岁的既往健康男孩身上。临床表现最初以肾病范围蛋白尿和严重高血压为主,随后出现肾衰竭。高剂量羟钴胺素的特异性治疗迅速使TMA缓解,肾功能完全恢复。我们得出结论,无论年龄大小,任何患有TMA和/或肾病综合征的患者的诊断检查都应包括血浆同型半胱氨酸和蛋氨酸测定以及尿有机酸分析。